3/27
06:35 pm
iron
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Neutral
Report
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
3/27
09:00 am
iron
Disc Medicine, Inc. Investigated by the Portnoy Law Firm
Low
Report
Disc Medicine, Inc. Investigated by the Portnoy Law Firm
3/26
05:22 pm
iron
Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria [Yahoo! Finance]
Low
Report
Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria [Yahoo! Finance]
3/26
04:30 pm
iron
Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria
Medium
Report
Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria
3/26
10:00 am
iron
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
3/25
09:00 am
iron
IRON Investors Lose Up to $22/Share -- LEVI & KORSINSKY, LLP Investigates Disc Medicine
Medium
Report
IRON Investors Lose Up to $22/Share -- LEVI & KORSINSKY, LLP Investigates Disc Medicine
3/24
05:51 pm
iron
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Disc Medicine, Inc. – IRON
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Disc Medicine, Inc. – IRON
3/24
01:57 pm
iron
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights [TheStreet.com]
Low
Report
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights [TheStreet.com]
3/24
01:33 pm
iron
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Low
Report
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
3/21
10:23 am
iron
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Low
Report
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
3/20
04:10 pm
iron
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
Low
Report
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
3/19
12:56 pm
iron
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation – IRON
Low
Report
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation – IRON
3/19
09:00 am
iron
IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP Investigates
Low
Report
IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP Investigates
3/18
10:20 am
iron
IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm
Low
Report
IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm
3/18
09:00 am
iron
IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP Investigates
Low
Report
IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP Investigates
3/14
05:39 pm
iron
IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm
Low
Report
IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm
3/12
09:00 am
iron
IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP Investigates
Medium
Report
IRON Drops Up to 39% After FDA CRL for Bitopertin -- LEVI & KORSINSKY, LLP Investigates
3/11
09:00 am
iron
IRON Investors Lose Up to $22/Share -- LEVI & KORSINSKY, LLP Investigates Disc Medicine
Medium
Report
IRON Investors Lose Up to $22/Share -- LEVI & KORSINSKY, LLP Investigates Disc Medicine
3/10
08:44 pm
iron
Evaluating Disc Medicine (IRON) After Recent Share Moves And Conflicting Valuation Signals [Yahoo! Finance]
Medium
Report
Evaluating Disc Medicine (IRON) After Recent Share Moves And Conflicting Valuation Signals [Yahoo! Finance]
3/3
03:37 pm
iron
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
3/2
10:56 am
iron
Disc Medicine (IRON) had its price target raised by Wells Fargo & Company from $78.00 to $79.00. They now have an "overweight" rating on the stock.
Low
Report
Disc Medicine (IRON) had its price target raised by Wells Fargo & Company from $78.00 to $79.00. They now have an "overweight" rating on the stock.
3/1
02:36 pm
iron
Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection [Yahoo! Finance]
Medium
Report
Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection [Yahoo! Finance]
2/28
10:27 am
iron
Disc Medicine (IRON) Is Up 8.6% After Wider 2025 Losses And New Shelf Registration - What's Changed [Yahoo! Finance]
Medium
Report
Disc Medicine (IRON) Is Up 8.6% After Wider 2025 Losses And New Shelf Registration - What's Changed [Yahoo! Finance]
2/27
01:11 pm
iron
Disc Medicine (IRON) had its price target lowered by Truist Financial Corporation from $114.00 to $83.00. They now have a "buy" rating on the stock.
Low
Report
Disc Medicine (IRON) had its price target lowered by Truist Financial Corporation from $114.00 to $83.00. They now have a "buy" rating on the stock.
2/26
03:12 pm
iron
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON